Amedeo Smart

Free Medical Literature Service

 

Amedeo

Alzheimer's Disease
  Free Subscription

Articles published in
Neurobiol Aging
    July 2025
  1. NAJDEK C, Walle P, Flaig A, Ayral AM, et al
    Calpain and caspase regulate Abeta peptide production via cleavage of KINDLIN2 encoded by the AD-associated gene FERMT2.
    Neurobiol Aging. 2025;151:117-125.
    >> Share

  2. PELEGRINI LNC, Manzine PR, Popolin CP, Dorta S, et al
    Higher soluble ADAM10 plasma levels are associated with decreased cognitive performance in older adults carrying APOEepsilon4.
    Neurobiol Aging. 2025;151:70-75.
    >> Share

  3. LUO T, Vattathil SM, Lori A, Schneider JA, et al
    Brain microRNAs differentially expressed in age-related cerebral pathologies.
    Neurobiol Aging. 2025;151:42-53.
    >> Share

    June 2025
  4. ORCIANI C, Foret MK, Cuello AC, Do Carmo S, et al
    Long-term nucleus basalis cholinergic lesions alter the structure of cortical vasculature, astrocytic density and microglial activity in Wistar rats.
    Neurobiol Aging. 2025;150:132-145.
    >> Share

    May 2025
  5. ALBERTAZZI A, Murphy C
    Brain activation in older adults during odor identification is related to ApoE, t-tau/Abeta(1-42), and hippocampal volume.
    Neurobiol Aging. 2025;149:44-53.
    >> Share

  6. SANAMI S, Intzandt B, Huck J, Villeneuve S, et al
    Longitudinal relationships among cerebrospinal fluid biomarkers, cerebral blood flow, and grey matter volume in individuals with a familial history of Alzheimer's disease.
    Neurobiol Aging. 2025;152:43-53.
    >> Share

    April 2025
  7. MCKEAN NE, Liu J, Rudiger SR, Kelly JM, et al
    Presenilin 1 hemizygosity has no overt deleterious phenotypic outcomes in sheep: Potential implications for therapeutic targets in Alzheimer's disease.
    Neurobiol Aging. 2025;152:25-33.
    >> Share

  8. PAITEL ER, Pettigrew C, Moghekar A, Miller MI, et al
    Alzheimer's disease cerebrospinal fluid biomarker levels and APOE genetic status are associated with hippocampal-cerebellar functional connectivity.
    Neurobiol Aging. 2025;151:107-116.
    >> Share

  9. ZAFARJAFARZADEH N, Feridouni E, Sobhani-Moghaddam S, Amini J, et al
    Dynamics and role of covalently-closed circular RNAs in Alzheimer's disease: A review of experimental and bioinformatics studies.
    Neurobiol Aging. 2025;151:54-69.
    >> Share

  10. RUSSELL JK, Conley AC, Boyd BD, Begnoche JP, et al
    Differences in cholinergic terminal density in adults with Down syndrome compared to neurotypical controls measured by [(18)F]-fluoroethoxybenzovesamicol positron emission tomography imaging.
    Neurobiol Aging. 2025;148:50-60.
    >> Share

  11. MCDERMOTT KE, Barnes CA
    Stability of locus coeruleus cell counts despite volume loss in cognitively impaired aged rhesus macaques.
    Neurobiol Aging. 2025;148:41-49.
    >> Share

  12. HOJJATI SH, Butler TA, de Leon M, Gupta A, et al
    Inter-network functional connectivity increases by beta-amyloid and may facilitate the early stage of tau accumulation.
    Neurobiol Aging. 2025;148:16-26.
    >> Share

    March 2025
  13. HRYBOUSKI S, Das SR, Xie L, Brown CA, et al
    BOLD amplitude correlates of preclinical Alzheimer's disease.
    Neurobiol Aging. 2025;150:157-171.
    >> Share

  14. LAVROVA A, Pham NTT, Reid RI, Boeve BF, et al
    Relation of Alzheimer's disease-related TDP-43 proteinopathy to metrics from diffusion tensor imaging (DTI) and neurite orientation dispersion and density imaging (NODDI).
    Neurobiol Aging. 2025;150:97-108.
    >> Share

  15. TREMBLAY SA, Nathan Spreng R, Wearn A, Alasmar Z, et al
    Sex and APOE4-specific links between cardiometabolic risk factors and white matter alterations in individuals with a family history of Alzheimer's disease.
    Neurobiol Aging. 2025;150:80-96.
    >> Share

    February 2025
  16. QIANG Q, Skudder-Hill L, Toyota T, Huang Z, et al
    CSF alpha-synuclein aggregation is associated with APOE epsilon4 and progressive cognitive decline in Alzheimer's disease.
    Neurobiol Aging. 2025;150:9-18.
    >> Share

  17. BUSSY A, Patel R, Parent O, Salaciak A, et al
    Exploring morphological and microstructural signatures across the Alzheimer's spectrum and risk factors.
    Neurobiol Aging. 2025;149:1-18.
    >> Share

  18. MEUNIER-DUPERRAY L, Souchay C, Angel L, Salmon E, et al
    Exploring the domain specificity and the neural correlates of memory unawareness in Alzheimer's disease.
    Neurobiol Aging. 2025;148:61-70.
    >> Share

    January 2025
  19. AL SHAMSI HSS, Gardener SL, Rainey-Smith SR, Pedrini S, et al
    The moderating effect of diet on the relationship between depressive symptoms and Alzheimer's disease-related blood-based biomarkers.
    Neurobiol Aging. 2025;147:213-222.
    >> Share

  20. PAVULURI K, Huston J 3rd, Ehman RL, Manduca A, et al
    Brain mechanical properties predict longitudinal cognitive change in aging and Alzheimer's disease.
    Neurobiol Aging. 2025;147:203-212.
    >> Share

  21. TAKAHASHI MKN, Paradela RS, Grinberg LT, Leite REP, et al
    Hypertension may associate with cerebral small vessel disease and infarcts through the pathway of intracranial atherosclerosis.
    Neurobiol Aging. 2025;145:84-95.
    >> Share

  22. CHEN X, Juarez A, Mason S, Kobayashi S, et al
    Longitudinal relationships between Abeta and tau to executive function and memory in cognitively normal older adults.
    Neurobiol Aging. 2025;145:32-41.
    >> Share

    December 2024
  23. CAPOGNA E, Sorensen O, Watne LO, Roe J, et al
    Subtypes of brain change in aging and their associations with cognition and Alzheimer's disease biomarkers.
    Neurobiol Aging. 2024;147:124-140.
    >> Share

  24. WINFREE RL, Nolan E, Blennow K, Zetterberg H, et al
    Vascular endothelial growth factor receptor-1 (FLT1) interactions with amyloid-beta in Alzheimer's disease: A putative biomarker of amyloid-induced vascular damage.
    Neurobiol Aging. 2024;147:141-149.
    >> Share

  25. RODRIGUES B, Ventura E, Moreira P, Resende R, et al
    New low-dose curcumin derivative with therapeutic potential in Alzheimer's disease: Results from an in vitro and in vivo study in mice.
    Neurobiol Aging. 2024;147:105-123.
    >> Share

  26. VERONELLI L, Tosi G, Romano D
    Modeling functional loss in Alzheimer's Disease through cognitive reserve and cognitive state: A panel data longitudinal study.
    Neurobiol Aging. 2024;147:60-67.
    >> Share

  27. BERNARDO AM, Marcotte M, Wong K, Sharmin D, et al
    Procognitive and neurotrophic benefits of alpha5-GABA-A receptor positive allosteric modulation in a beta-amyloid deposition mouse model of Alzheimer's disease pathology.
    Neurobiol Aging. 2024;147:49-59.
    >> Share

  28. PIEVANI M, Ribaldi F, Toussas K, Da Costa S, et al
    Resting-state functional connectivity abnormalities in subjective cognitive decline: A 7T MRI study.
    Neurobiol Aging. 2024;144:104-113.
    >> Share

  29. DENG F, Dounavi ME, Plini ERG, Ritchie K, et al
    Cardiovascular risk of dementia is associated with brain-behaviour changes in cognitively healthy, middle-aged individuals.
    Neurobiol Aging. 2024;144:78-92.
    >> Share

  30. ALSEGIANI AS, Shah ZA
    Age-dependent sex differences in cofilin1 pathway (LIMK1/SSH1) and its association with AD biomarkers after chronic systemic inflammation in mice.
    Neurobiol Aging. 2024;144:43-55.
    >> Share

  31. BAMFORD AR, Adams JN, Kim S, McMillan LC, et al
    The amyloid beta 42/38 ratio as a plasma biomarker of early memory deficits in cognitively unimpaired older adults.
    Neurobiol Aging. 2024;144:12-18.
    >> Share

    November 2024
  32. DUTT S, Bachman SL, Dahl MJ, Li Y, et al
    Locus coeruleus MRI contrast, cerebral perfusion, and plasma Alzheimer's disease biomarkers in older adults.
    Neurobiol Aging. 2024;147:12-21.
    >> Share

  33. DENKINGER M, Baker S, Harrison TM, Chadwick T, et al
    Cross-sectional and longitudinal relationships among blood-brain barrier disruption, Alzheimer's disease biomarkers, and cognition in cognitively normal older adults.
    Neurobiol Aging. 2024;146:15-23.
    >> Share

  34. SORDO L, Ubele MF, Boaz KA, Mefford JL, et al
    Calcineurin/NFAT inhibitors maintain cognition in a preclinical prevention study in an aging canine model of Alzheimer disease.
    Neurobiol Aging. 2024;146:1-14.
    >> Share

  35. YE Z, Pan Y, McCoy RG, Bi C, et al
    Contrasting association pattern of plasma low-density lipoprotein with white matter integrity in APOE4 carriers versus non-carriers.
    Neurobiol Aging. 2024;143:41-52.
    >> Share

  36. BEER S, Elmenhorst D, Bischof GN, Ramirez A, et al
    Explainable artificial intelligence identifies an AQP4 polymorphism-based risk score associated with brain amyloid burden.
    Neurobiol Aging. 2024;143:19-29.
    >> Share

    October 2024
  37. LU W, Shue F, Kurti A, Jeevaratnam S, et al
    Amyloid pathology and cognitive impairment in hAbeta-KI and APP(SAA)-KI mouse models of Alzheimer's disease.
    Neurobiol Aging. 2024;145:13-23.
    >> Share

  38. DAVIES-JENKINS CW, Workman CI, Hupfeld KE, Zollner HJ, et al
    Multimodal investigation of neuropathology and neurometabolites in mild cognitive impairment and late-life depression with (11)C-PiB beta-amyloid PET and 7T magnetic resonance spectroscopy.
    Neurobiol Aging. 2024;142:27-40.
    >> Share

    September 2024
  39. MACEDO AC, Therriault J, Tissot C, Aumont E, et al
    Modeling the progression of neuropsychiatric symptoms in Alzheimer's disease with PET-based Braak staging.
    Neurobiol Aging. 2024;144:127-137.
    >> Share

  40. GAUTIER MK, Kelley CM, Lee SH, Mufson EJ, et al
    Maternal choline supplementation rescues early endosome pathology in basal forebrain cholinergic neurons in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.
    Neurobiol Aging. 2024;144:30-42.
    >> Share

  41. JIMENEZ-BALADO J, Habeck C, Stern Y, Eich T, et al
    The relationship between cortical thickness and white matter hyperintensities in mid to late life.
    Neurobiol Aging. 2024;141:129-139.
    >> Share

  42. KARIM HT, Lee S, Gerlach A, Stinley M, et al
    Hippocampal subfield volume in older adults with and without mild cognitive impairment: Effects of worry and cognitive reappraisal.
    Neurobiol Aging. 2024;141:55-65.
    >> Share

    August 2024
  43. PEREZ-MILLAN A, Thirion B, Falgas N, Borrego-Ecija S, et al
    Beyond group classification: Probabilistic differential diagnosis of frontotemporal dementia and Alzheimer's disease with MRI and CSF biomarkers.
    Neurobiol Aging. 2024;144:1-11.
    >> Share

  44. QUARESIMA V, Pilotto A, Trasciatti C, Tolassi C, et al
    Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA.
    Neurobiol Aging. 2024;143:30-40.
    >> Share

  45. CAVALLARI M, Touroutoglou A, Katsumi Y, Fong TG, et al
    Relationship between cortical brain atrophy, delirium, and long-term cognitive decline in older surgical patients.
    Neurobiol Aging. 2024;140:130-139.
    >> Share

  46. LIBRI I, Silvestri C, Caratozzolo S, Alberici A, et al
    Association of APOE genotype with blood-brain barrier permeability in neurodegenerative disorders.
    Neurobiol Aging. 2024;140:33-40.
    >> Share

    July 2024
  47. KAPOOR A, Dutt S, Alitin JPM, Sible IJ, et al
    Older adults with reduced cerebrovascular reactivity exhibit high white matter hyperintensity burden.
    Neurobiol Aging. 2024;139:5-10.
    >> Share

    June 2024
  48. DE AVILA C, Suazo C, Nolz J, Nicholas Cochran J, et al
    Reduced PIN1 expression in neocortical and limbic brain regions in female Alzheimer's patients correlates with cognitive and neuropathological phenotypes.
    Neurobiol Aging. 2024;141:160-170.
    >> Share

  49. CHATTERJEE A, Lee S, Diaz V, Saloner R, et al
    Associations of cerebrovascular disease and Alzheimer's disease pathology with cognitive decline: Analysis of the National Alzheimer's Coordinating Center Uniform Data Set.
    Neurobiol Aging. 2024;142:1-7.
    >> Share

  50. VAN AMERONGEN S, Das S, Kamps S, Goossens J, et al
    Cerebrospinal fluid biomarkers and cognitive trajectories in patients with Alzheimer's disease and a history of traumatic brain injury.
    Neurobiol Aging. 2024;141:121-128.
    >> Share

  51. BRANSBY L, Yassi N, Rosenich E, Buckley R, et al
    Associations between multidomain modifiable dementia risk factors with AD biomarkers and cognition in middle-aged and older adults.
    Neurobiol Aging. 2024;138:63-71.
    >> Share

  52. RODRIGUEZ-FERNANDEZ B, Sanchez-Benavides G, Genius P, Minguillon C, et al
    Association between telomere length and cognitive function among cognitively unimpaired individuals at risk of Alzheimer's disease.
    Neurobiol Aging. 2024;141:140-150.
    >> Share

    May 2024
  53. KNUDTZON SL, Nordengen K, Grontvedt GR, Jarholm J, et al
    Age-adjusted CSF t-tau and NfL do not improve diagnostic accuracy for prodromal Alzheimer's disease.
    Neurobiol Aging. 2024;141:74-84.
    >> Share

  54. LIU R, Li JZ, Song JK, Zhou D, et al
    Corrigendum to: "Pinocembrin improves cognition and protects the neurovascular unit in Alzheimer related deficits" [Neurobiol. Aging 35 (2014) 1275-1285].
    Neurobiol Aging. 2024 May 22:S0197-4580(24)00101.
    >> Share

  55. YANG Q, Zhou X, Ma T
    Isoform-specific effects of neuronal inhibition of AMPK catalytic subunit on LTD impairments in a mouse model of Alzheimer's disease.
    Neurobiol Aging. 2024;140:116-121.
    >> Share

  56. BERNOCCHI F, Bonomi CG, Assogna M, Moreschini A, et al
    Astrocytic-derived vascular remodeling factors are independently associated with blood brain barrier permeability in Alzheimer's disease.
    Neurobiol Aging. 2024;141:66-73.
    >> Share

  57. LOPEZ S, Hampel H, Chiesa PA, Del Percio C, et al
    The association between posterior resting-state EEG alpha rhythms and functional MRI connectivity in older adults with subjective memory complaint.
    Neurobiol Aging. 2024;137:62-77.
    >> Share

  58. POOLE VN, Ridwan AR, Arfanakis K, Dawe RJ, et al
    Associations of brain morphology with cortical proteins of cognitive resilience.
    Neurobiol Aging. 2024;137:1-7.
    >> Share

    April 2024
  59. WINFREE RL, Erreger K, Phillips J, Seto M, et al
    Elevated protease-activated receptor 4 (PAR4) gene expression in Alzheimer's disease predicts cognitive decline.
    Neurobiol Aging. 2024;140:93-101.
    >> Share

  60. JANG I, Li B, Rashid B, Jacoby J, et al
    Brain structural indicators of beta-amyloid neuropathology.
    Neurobiol Aging. 2024;136:157-170.
    >> Share

  61. ROBINSON B, Bhamidi S, Dayan E
    The spatial distribution of coupling between tau and neurodegeneration in amyloid-beta positive mild cognitive impairment.
    Neurobiol Aging. 2024;136:70-77.
    >> Share

  62. WHITMAN ET, Ryan CP, Abraham WC, Addae A, et al
    A blood biomarker of the pace of aging is associated with brain structure: replication across three cohorts.
    Neurobiol Aging. 2024;136:23-33.
    >> Share

    March 2024
  63. NENCHA U, Rigoni I, Ribaldi F, Altomare D, et al
    Alterations in gamma frequency oscillations correlate with cortical tau deposition in Alzheimer's disease.
    Neurobiol Aging. 2024;139:1-4.
    >> Share

  64. ROYSE SK, Snitz BE, Hill AV, Reese AC, et al
    Apolipoprotein E and Alzheimer's disease pathology in African American older adults.
    Neurobiol Aging. 2024;139:11-19.
    >> Share

  65. SHAFIEE N, Fonov V, Dadar M, Spreng RN, et al
    Degeneration in Nucleus basalis of Meynert signals earliest stage of Alzheimer's disease progression.
    Neurobiol Aging. 2024;139:54-63.
    >> Share

  66. INAGAKI R, Yamakuni T, Saito T, Saido TC, et al
    Preventive effect of propolis on cognitive decline in Alzheimer's disease model mice.
    Neurobiol Aging. 2024;139:20-29.
    >> Share

  67. ALMEIDA FC, Jesus T, Coelho A, Quintas-Neves M, et al
    Psychosis in Alzheimer's disease is associated with specific changes in brain MRI volume, cognition and neuropathology.
    Neurobiol Aging. 2024;138:10-18.
    >> Share

  68. TAGHVAEI M, Mechanic-Hamilton DJ, Sadaghiani S, Shakibajahromi B, et al
    Impact of white matter hyperintensities on structural connectivity and cognition in cognitively intact ADNI participants.
    Neurobiol Aging. 2024;135:79-90.
    >> Share

  69. ZHANG YN, Chen XL, Guo LY, Jiang PR, et al
    Downregulation of peripheral luteinizing hormone rescues ovariectomy-associated cognitive deficits in APP/PS1 mice.
    Neurobiol Aging. 2024;135:60-69.
    >> Share

  70. HEMMINGHYTH MS, Chwiszczuk LJ, Breitve MH, Gisladottir B, et al
    Cerebrospinal fluid neurofilament light chain mediates age-associated lower learning and memory in healthy adults.
    Neurobiol Aging. 2024;135:39-47.
    >> Share

  71. BABILONI C, Noce G, Tucci F, Jakhar D, et al
    Poor reactivity of posterior electroencephalographic alpha rhythms during the eyes open condition in patients with dementia due to Parkinson's disease.
    Neurobiol Aging. 2024;135:1-14.
    >> Share

    February 2024
  72. YILDIRIM E, Akturk T, Hanoglu L, Yener G, et al
    Lower oddball event-related EEG delta and theta responses in patients with dementia due to Parkinson's and Lewy body than Alzheimer's disease.
    Neurobiol Aging. 2024;137:78-93.
    >> Share

  73. NAUDE J, Wang M, Leon R, Smith E, et al
    Tau-PET in early cortical Alzheimer brain regions in relation to mild behavioral impairment in older adults with either normal cognition or mild cognitive impairment.
    Neurobiol Aging. 2024;138:19-27.
    >> Share

  74. AI M, Morris TP, Noriega de la Colina A, Thovinakere N, et al
    Midlife physical activity engagement is associated with later-life brain health.
    Neurobiol Aging. 2024;134:146-159.
    >> Share

  75. BABILONI C, Jakhar D, Tucci F, Del Percio C, et al
    Resting state electroencephalographic alpha rhythms are sensitive to Alzheimer's disease mild cognitive impairment progression at a 6-month follow-up.
    Neurobiol Aging. 2024;137:19-37.
    >> Share

    January 2024
  76. LAN F, Roquet D, Dalton MA, El-Omar H, et al
    Exploring graded profiles of hippocampal atrophy along the anterior-posterior axis in semantic dementia and Alzheimer's disease.
    Neurobiol Aging. 2024;135:70-78.
    >> Share

  77. FERRARI-SOUZA JP, Brum WS, Hauschild LA, Da Ros LU, et al
    Vascular risk burden is a key player in the early progression of Alzheimer's disease.
    Neurobiol Aging. 2024;136:88-98.
    >> Share

  78. CIAMPA CJ, Morin TM, Murphy A, Joie R, et al
    DAT1 and BDNF polymorphisms interact to predict Abeta and tau pathology.
    Neurobiol Aging. 2024;133:115-124.
    >> Share

  79. HALE MR, Langhough R, Du L, Hermann BP, et al
    Associations between recall of proper names in story recall and CSF amyloid and tau in adults without cognitive impairment.
    Neurobiol Aging. 2024;133:87-98.
    >> Share

  80. SOOD A, Capuano AW, Wilson RS, Barnes LL, et al
    Metformin, age-related cognitive decline, and brain pathology.
    Neurobiol Aging. 2024;133:99-106.
    >> Share

  81. TWITTO-GREENBERG R, Liraz-Zaltsman S, Michaelson DM, Liraz O, et al
    9-cis beta-carotene-enriched diet significantly improved cognition and decreased Alzheimer's disease neuropathology and neuroinflammation in Alzheimer's disease-like mouse models.
    Neurobiol Aging. 2024;133:16-27.
    >> Share

  82. SIMON SS, Varangis E, Lee S, Gu Y, et al
    In vivo tau is associated with change in memory and processing speed, but not reasoning, in cognitively unimpaired older adults.
    Neurobiol Aging. 2024;133:28-38.
    >> Share

    December 2023
  83. LEVIN F, Grothe MJ, Dyrba M, Franzmeier N, et al
    Longitudinal trajectories of cognitive reserve in hypometabolic subtypes of Alzheimer's disease.
    Neurobiol Aging. 2023;135:26-38.
    >> Share

  84. LAN G, Du J, Chen X, Wang Q, et al
    Association of APOE-epsilon4 and GAP-43-related presynaptic loss with beta-amyloid, tau, neurodegeneration, and cognitive decline.
    Neurobiol Aging. 2023;132:209-219.
    >> Share

  85. QIU T, Hong H, Zeng Q, Luo X, et al
    Degeneration of cholinergic white matter pathways and nucleus basalis of Meynert in individuals with objective subtle cognitive impairment.
    Neurobiol Aging. 2023;132:198-208.
    >> Share

  86. CATTERSON JH, Minkley L, Aspe S, Judd-Mole S, et al
    Protein retention in the endoplasmic reticulum rescues Abeta toxicity in Drosophila.
    Neurobiol Aging. 2023;132:154-174.
    >> Share

  87. KAN CN, Huang X, Zhang L, Hilal S, et al
    Comorbid amyloid with cerebrovascular disease in domain-specific cognitive and neuropsychiatric disturbances: a cross-sectional memory clinic study.
    Neurobiol Aging. 2023;132:47-55.
    >> Share

    November 2023
  88. CHIN KS, Holper S, Loveland P, Churilov L, et al
    Prevalence of cerebral microbleeds in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia: A systematic review and meta-analysis.
    Neurobiol Aging. 2023;134:74-83.
    >> Share

  89. LI JQ, Song JH, Suckling J, Wang YJ, et al
    Disease trajectories in older adults with non-AD pathologic change and comparison with Alzheimer's disease pathophysiology: A longitudinal study.
    Neurobiol Aging. 2023;134:106-114.
    >> Share

  90. ROCCATI E, Collins JM, Bindoff AD, Alty JE, et al
    Modifiable risk factors for dementia, cognition, and plasma phosphorylated tau 181 in a large-scale cohort of Australian older adults.
    Neurobiol Aging. 2023;131:106-114.
    >> Share

  91. GREGORY S, Blennow K, Ritchie CW, Shannon OM, et al
    Mediterranean diet is associated with lower white matter lesion volume in Mediterranean cities and lower cerebrospinal fluid Abeta(42) in non-Mediterranean cities in the EPAD LCS cohort.
    Neurobiol Aging. 2023;131:29-38.
    >> Share

  92. ZENUNI H, Bovenzi R, Bissacco J, Grillo P, et al
    Clinical and neurochemical correlates of the APOE genotype in early-stage Parkinson's disease.
    Neurobiol Aging. 2023;131:24-28.
    >> Share

  93. AKSNES M, Capogna E, Vidal-Pineiro D, Chaudhry FA, et al
    Matrix metalloproteinases are associated with brain atrophy in cognitively unimpaired individuals.
    Neurobiol Aging. 2023;131:11-23.
    >> Share

    October 2023
  94. NUYTEMANS K, Rajabli F, Jean-Francois M, Kurup JT, et al
    Genetic analyses in multiplex families confirms chromosome 5q35 as a risk locus for Alzheimer's Disease in individuals of African Ancestry.
    Neurobiol Aging. 2023;133:125-133.
    >> Share

  95. KANG S, Jeon S, Lee YG, Ye BS, et al
    Dopamine transporter positron emission tomography in patients with Alzheimer's disease with Lewy body disease features.
    Neurobiol Aging. 2023;134:57-65.
    >> Share

  96. LEE BN, Wang J, Hall MA, Kim D, et al
    Sex modifies effects of imaging and CSF biomarkers on cognitive and functional outcomes: a study of Alzheimer's disease.
    Neurobiol Aging. 2023;133:67-77.
    >> Share

  97. LI J, Chen D, Liu H, Xi Y, et al
    Identifying potential genetic epistasis implicated in Alzheimer's disease via detection of SNP-SNP interaction on quantitative trait CSF Abeta(42).
    Neurobiol Aging. 2023;134:84-93.
    >> Share

  98. COUGHLAN G, DeSouza B, Zhukovsky P, Hornberger M, et al
    Spatial cognition is associated with levels of phosphorylated-tau and beta-amyloid in clinically normal older adults.
    Neurobiol Aging. 2023;130:124-134.
    >> Share

  99. BEJIA I, Labidi J, Warniez A, Bayot M, et al
    Multi-approach comparative study of EEG patterns associated with the most common forms of dementia.
    Neurobiol Aging. 2023;130:30-39.
    >> Share

  100. LIZIO R, Lopez S, Babiloni C, Del Percio C, et al
    Resting state EEG rhythms in different stages of chronic kidney disease with mild cognitive impairment.
    Neurobiol Aging. 2023;130:70-79.
    >> Share

    September 2023
  101. ZHU M, Gu H, Bai H, Li Y, et al
    Role and molecular regulatory mechanisms of Hippo signaling pathway in Caenorhabditis elegans and mammalian cell models of Alzheimer's disease.
    Neurobiol Aging. 2023;134:9-20.
    >> Share

  102. AERQIN Q, Chen XT, Ou YN, Ma YH, et al
    Associations between multimorbidity burden and Alzheimer's pathology in older adults without dementia: the CABLE study.
    Neurobiol Aging. 2023;134:1-8.
    >> Share

  103. ORCIANI C, Do Carmo S, Foret MK, Hall H, et al
    Early treatment with an M1 and sigma-1 receptor agonist prevents cognitive decline in a transgenic rat model displaying Alzheimer-like amyloid pathology.
    Neurobiol Aging. 2023;132:220-232.
    >> Share

  104. HONEA RA, Hunt S, Lepping RJ, Vidoni ED, et al
    Alzheimer's disease cortical morphological phenotypes are associated with TOMM40'523-APOE haplotypes.
    Neurobiol Aging. 2023;132:131-144.
    >> Share

  105. XIA Y, Maruff P, Dore V, Bourgeat P, et al
    Longitudinal trajectories of basal forebrain volume in normal aging and Alzheimer's disease.
    Neurobiol Aging. 2023;132:120-130.
    >> Share

  106. LIM YY, Yassi N, Bransby L, Ayton S, et al
    CSF Abeta(42) and tau biomarkers in cognitively unimpaired Abeta- middle-aged and older APOE epsilon4 carriers.
    Neurobiol Aging. 2023;129:209-218.
    >> Share

  107. ALCHERA N, Garibotto V, Tomczyk S, Treyer V, et al
    Patterns of amyloid accumulation in amyloid-negative cases.
    Neurobiol Aging. 2023;129:99-108.
    >> Share

  108. NIKSERESHT G, Evia AM, Nag S, Leurgans SE, et al
    Neuropathologic correlates of cerebral microbleeds in community-based older adults.
    Neurobiol Aging. 2023;129:89-98.
    >> Share

  109. JONES KT, Gallen CL, Ostrand AE, Rojas JC, et al
    Gamma neuromodulation improves episodic memory and its associated network in amnestic mild cognitive impairment: a pilot study.
    Neurobiol Aging. 2023;129:72-88.
    >> Share

  110. RENNIE A, Ekman U, Wallert J, Muehlboeck JS, et al
    Comparing three neuropsychological subgrouping approaches in subjective and mild cognitive impairment from a naturalistic multicenter study.
    Neurobiol Aging. 2023;129:41-49.
    >> Share

    August 2023
  111. HOY KE, Emonson MRL, Bailey NW, Rogers C, et al
    Gamma connectivity predicts response to intermittent theta burst stimulation in Alzheimer's disease: a randomized controlled trial.
    Neurobiol Aging. 2023;132:13-23.
    >> Share

  112. TUBI MA, Wheeler K, Matsiyevskiy E, Hapenney M, et al
    White matter hyperintensity volume modifies the association between CSF vascular inflammatory biomarkers and regional FDG-PET along the Alzheimer's disease continuum.
    Neurobiol Aging. 2023;132:1-12.
    >> Share

  113. MOALLEMIAN S, Salmon E, Bahri MA, Beliy N, et al
    Multimodal imaging of microstructural cerebral alterations and loss of synaptic density in Alzheimer's disease.
    Neurobiol Aging. 2023;132:24-35.
    >> Share

  114. TERRACCIANO A, Walker K, An Y, Luchetti M, et al
    The association between personality and plasma biomarkers of astrogliosis and neuronal injury.
    Neurobiol Aging. 2023;128:65-73.
    >> Share

  115. KAPOOR A, Gaubert A, Yew B, Jang JY, et al
    Enlarged perivascular spaces and plasma Abeta42/Abeta40 ratio in older adults without dementia.
    Neurobiol Aging. 2023;128:43-48.
    >> Share

    July 2023
  116. COLMANT L, Bierbrauer A, Bellaali Y, Kunz L, et al
    Dissociating effects of aging and genetic risk of sporadic Alzheimer's disease on path integration.
    Neurobiol Aging. 2023;131:170-181.
    >> Share

  117. GROECHEL RC, Tripodis Y, Alosco ML, Mez J, et al
    Biomarkers of Alzheimer's disease in Black and/or African American Alzheimer's Disease Neuroimaging Initiative (ADNI) participants.
    Neurobiol Aging. 2023;131:144-152.
    >> Share

  118. CUKIER HN, Duarte CL, Laverde-Paz MJ, Simon SA, et al
    An Alzheimer's disease risk variant in TTC3 modifies the actin cytoskeleton organization and the PI3K-Akt signaling pathway in iPSC-derived forebrain neurons.
    Neurobiol Aging. 2023;131:182-195.
    >> Share

  119. ISELLA V, Licciardo D, Rebecchi G, Ferri F, et al
    A cognitive marker for Alzheimer disease pathology in primary progressive aphasia? A validation study in the clinical setting.
    Neurobiol Aging. 2023;131:153-155.
    >> Share

  120. SU Z, Zhang G, Li X, Zhang H, et al
    Inverse correlation between Alzheimer's disease and cancer from the perspective of hypoxia.
    Neurobiol Aging. 2023;131:59-73.
    >> Share

  121. GROECHEL RC, Tripodis Y, Alosco ML, Mez J, et al
    Annualized changes in rate of amyloid deposition and neurodegeneration are greater in participants who become amyloid positive than those who remain amyloid negative.
    Neurobiol Aging. 2023;127:33-42.
    >> Share

    June 2023
  122. SWINFORD CG, Risacher SL, Vosmeier A, Deardorff R, et al
    Amyloid and tau pathology are associated with cerebral blood flow in a mixed sample of nondemented older adults with and without vascular risk factors for Alzheimer's disease.
    Neurobiol Aging. 2023;130:103-113.
    >> Share

  123. PAN F, Wang Y, Wang Y, Wang X, et al
    Sex and APOE genotype differences in amyloid deposition and cognitive performance along the Alzheimer's Continuum.
    Neurobiol Aging. 2023;130:84-92.
    >> Share

  124. FRICK A, Besson G, Salmon E, Delhaye E, et al
    Perirhinal cortex is associated with fine-grained discrimination of conceptually confusable objects in Alzheimer's disease.
    Neurobiol Aging. 2023;130:1-11.
    >> Share

  125. INAYAT S, McAllister BB, Chang H, Lacoursiere SG, et al
    Weak-hyperactive hippocampal CA1 neurons in the prodromal stage of Alzheimer's disease in hybrid App(NL-G-F/NL-G-F) x Thy1-GCaMP6s(+/-) mice suggest disrupted plasticity.
    Neurobiol Aging. 2023;130:154-171.
    >> Share

  126. HOPKINS WD, Li X, Roberts N, Mulholland MM, et al
    Age differences in cortical thickness and their association with cognition in chimpanzee (Pan troglodytes).
    Neurobiol Aging. 2023;126:91-102.
    >> Share

    May 2023
  127. FLORES-SANDOVAL AA, Davila-Perez P, Buss SS, Donohoe K, et al
    Spectral power ratio as a measure of EEG changes in mild cognitive impairment due to Alzheimer's disease: a case-control study.
    Neurobiol Aging. 2023;130:50-60.
    >> Share

  128. SUN Z, Zhao C, Liu X, Zhang P, et al
    Mutation analysis of the ECE1 gene in late-onset Alzheimer's disease.
    Neurobiol Aging. 2023;129:58-61.
    >> Share

  129. WILLIAMS ME, Elman JA, Bell TR, Dale AM, et al
    Higher cortical thickness/volume in Alzheimer's-related regions: protective factor or risk factor?
    Neurobiol Aging. 2023;129:185-194.
    >> Share

  130. MIKKELSEN JD, Kaad S, Aripaka SS, Finsen B, et al
    Synaptic vesicle glycoprotein 2A (SV2A) levels in the cerebral cortex in patients with Alzheimer's disease: a radioligand binding study in postmortem brains.
    Neurobiol Aging. 2023;129:50-57.
    >> Share

  131. WEIGAND AJ, Ortiz G, Walker KS, Galasko DR, et al
    APOE differentially moderates cerebrospinal fluid and plasma phosphorylated tau181 associations with multi-domain cognition.
    Neurobiol Aging. 2023;125:1-8.
    >> Share

    April 2023
  132. PAPADATOS Z, Phillips NA
    Olfactory function reflects episodic memory performance and atrophy in the medial temporal lobe in individuals at risk for Alzheimer's disease.
    Neurobiol Aging. 2023;128:33-42.
    >> Share

  133. SOTO PL, Young ME, DiMarco GM, George B, et al
    Longitudinal assessment of cognitive function in the APPswe/PS1dE9 mouse model of Alzheimer's-related beta-amyloidosis.
    Neurobiol Aging. 2023 Apr 2:S0197-4580(23)00062.
    >> Share

    March 2023
  134. KASUGA K, Tsukie T, Kikuchi M, Tokutake T, et al
    The clinical application of optimized AT(N) classification in Alzheimer's clinical syndrome (ACS) and non-ACS conditions.
    Neurobiol Aging. 2023;127:23-32.
    >> Share

  135. WIGHTMAN DP, Savage JE, Tissink E, Romero C, et al
    The genetic overlap between Alzheimer's disease, amyotrophic lateral sclerosis, Lewy body dementia, and Parkinson's disease.
    Neurobiol Aging. 2023 Mar 12:S0197-4580(23)00050.
    >> Share

  136. NA H, Yang JB, Zhang Z, Gan Q, et al
    Peripheral apolipoprotein E proteins and their binding to LRP1 antagonize Alzheimer's disease pathogenesis in the brain during peripheral chronic inflammation.
    Neurobiol Aging. 2023;127:54-69.
    >> Share

  137. KESZYCKI R, Rodriguez G, Dunn JT, Locci A, et al
    Characterization of apathy-like behaviors in the 5xFAD mouse model of Alzheimer's disease.
    Neurobiol Aging. 2023;126:113-122.
    >> Share

    February 2023
  138. SUPIYEV A, Karlsson R, Wang Y, Koch E, et al
    Independent role of Alzheimer's disease genetics and C-reactive protein on cognitive ability in aging.
    Neurobiol Aging. 2023;126:103-112.
    >> Share

  139. KIM BJ, Grossman M, Aleman TS, Song D, et al
    Retinal photoreceptor layer thickness has disease specificity and distinguishes predicted FTLD-Tau from biomarker-determined Alzheimer's disease.
    Neurobiol Aging. 2023;125:74-82.
    >> Share

  140. KELBERMAN MA, Rorabaugh JM, Anderson CR, Marriott A, et al
    Age-dependent dysregulation of locus coeruleus firing in a transgenic rat model of Alzheimer's disease.
    Neurobiol Aging. 2023;125:98-108.
    >> Share

    January 2023
  141. SETO M, Dumitrescu L, Mahoney ER, Sclafani AM, et al
    Multi-omic characterization of brain changes in the vascular endothelial growth factor family during aging and Alzheimer's disease.
    Neurobiol Aging. 2023;126:25-33.
    >> Share

    December 2022
  142. ZHU M, Hou T, Jia L, Tan Q, et al
    Development and validation of a 13-gene signature associated with immune function for the detection of Alzheimer's disease.
    Neurobiol Aging. 2022;125:62-73.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016